The binding of interferons to distinct cell surface receptors leads to the induction of synthesis of several unique polypeptides and their corresponding mRNAs (1) (2) (3) (4) (5) (6) (8, 9) . One of these cDNA clones is complementary to the mRNA for a 56-kDa protein (8), and the other, to the mRNA for 2',5'-oligo(A) synthetase (9), both of which are prominent IFN-induced protein products (7) . Whether this increase in specific mRNA is based on increased transcription and/or increased stabilization of the mRNA in the cytoplasm has not been determined.
has not been determined.
In fact, whether transcriptional increases underlie the numerous biologic effects mediated by the binding of peptide hormones, growth factors, and lectins to their specific plasma membrane receptors is at present largely unknown. It is also unclear whether a polypeptide can effect an increase in specific mRNA concentration, particularly by transcriptional control, without entering the cell. Molecules such as cyclic AMP or Ca2+ or analogous "second messengers" could mediate the transcriptional stimulation of specific genes after an initial hormone-receptor interaction. Likewise, the effect of intracellular tyrosine kinase activities of membrane receptor proteins is under intense investigation, but no specific transcriptional activations have been documented as a result of these enzyme activities.
A few cases have been analyzed that support the hypothesis of second messengers as transcriptional activators. Thyrotropin-releasing hormone (TRH) and epidermal growth factor (EGF) increase transcription of the prolactin gene in a pituitary cell line (10, 11) . The effects of TRH can be mimicked by cyclic AMP treatment of the pituitary tumor cells. EFG-induced prolactin mRNA accumulation requires extracellular Ca2 , which implies that increased free intracellular Ca2+ is involved in the mediation of this hormone's action (12) . In another case, insulin causes a 30-40% inhibition of the transcription of phosphoenolpyruvate carboxykinase (13) . One case of a protein hormone effecting an increase in a specific mRNA largely through mRNA stabilization is known. Prolactin increases casein mRNA concentration by a factor of 100 in mammary gland organ cultures (14) , but transcription of casein mRNA increases only about 3-fold. Stabilization accounts for the majority of increased cytoplasmic mRNA concentration. Recently, mRNAs have been described that are increased after treatment of cells with platelet-derived growth factor (15) or serum stimulation of resting cells (16) . In these cases the level of control of the increased mRNAs has not yet been reported.
The mechanism of IFN action on gene control is an experimentally attractive instance of protein-induced cellular responses because (i) there are distinct cell-surface receptors for a, j3, and y IFNs (17), (ii) different proteins and mRNAs are induced by human IFNs of type 1 (IFN-a or -3) and type 2 (IFN-y) (2, 3, 6) , (iii) the IFNs apparently can induce the antiviral state without entering the cell (18) , and (iv) the mode of action of IFN is probably not through cyclic AMP (19) . Therefore, if IFN stimulates transcription of specific genes, it would represent an excellent system to study transcriptional control mediated from the plasma membrane. For this purpose, we have isolated two cDNA clones that are complementary to mRNA of IFN-,3-treated cells but not to mRNA of untreated cells. One of the two clones is complementary to a mRNA of about 1.9 kilobases (kb) that encodes an IFN-induced 56-kDa protein (8) . The second clone is complementary to a 2.9-kb mRNA. After treatment with IFN-f3 but not with IFN-y, the cytoplasmic mRNA concentration of both these mRNAs increases in both fibroblasts and HeLa cells. This increase results from a rapid increase in transcription of these genes that is maximal within 30-60 min.
METHODS AND MATERIALS
IFNs. Human IFN-p (103 units/mg) was produced and purified to homogeneity as described by Knight et al. (20) . Human IFN-y was purchased from Interferon Sciences (New Brunswick, NJ).
Cell Cultures. Human diploid fibroblasts were grown in Dulbecco's modified Eagle's medium (DME medium) containing 7% (vol/vol) fetal calf serum in 850-cm2 roller bottles (6) . Seven-to 8-day-old confluent monolayers were treated with IFN-f3 in 50 ml of medium containing 7% fetal calf serum and buffered with 20 mM Hepes (pH 7.2).
Isolation of mRNA and Labeling of Nascent RNA in Isolated Nuclei. Cells were rinsed and scraped into ice-cold phosphate-buffered saline, centrifuged, and resuspended on ice in 10 mM Tris, pH 7.4/10 mM NaCI/5 mM MgCl2/1 mM dithiothreitol (RSB) at 3-5 x 107 cells per ml. After swelling for 5 min, the cells were disrupted by Dounce homogenization, and nuclei were removed by centrifugation (3 min at 2000 x g). Cytoplasmic RNA was isolated as described by Salditt-Georgieff et al. (21) . For construction of a cDNA liAbbreviations: IFN-,3, interferon; TRH, thyrotropin-releasing hormone; EGF, epidermal growth factor; kb, kilobases.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. brary, cellular RNA was prepared by using guanidium isothiocyanate (22) . Poly(A)+ RNA was isolated by two cycles of purification on oligo(dT)-cellulose (23) . For transcriptional assay, the nuclei (5-50 x 107 per reaction) were resuspended in 5 ml of 20 mM Hepes, pH 7.9 at 250C/20% glycerol/140 mM KCl/10 mM MgCl2/1 mM dithiothreitol (nuclear reaction buffer) for 5 min at 40C, centrifuged, and resuspended in 200-400 gl of nuclear reaction buffer containing 1 mM each of ATP, GTP, and CTP; 3 ILM UTP; 0.2-0.5 mCi of [a-32P]UTP (3000 Ci/mmol; 1 Ci = 37 GBq). Nuclei were incubated for 15 min at 30'C. DNase buffer (10 mM Tris, pH 7.4/0.5 M NaCl/50 mM MgCl2/2 mM CaCl2/50 ,ug of DNase per ml) was added to a total of 2 ml, and nuclear RNA was extracted (21) and freed of unincorporated triphosphates by CC13COOH precipitation (24) .
Construction and Screening of Recombinant cDNA Clones. Poly(A)+ RNA (6 ug) was used to produce double-stranded cDNA with C tails. This was hybridized to G-tailed pBR322 cut at the Pst I site, ligated, and transfected into Escherichia coli (25) . Tetracycline-resistant colonies were isolated, and colony screens were carried out with 32P-labeled cDNA probes made from mRNA of IFN-treated or untreated fibroblasts. The conditions for colony hybridization were as described by Derman et al. (26) . The plasmid pIFN-IND-2 was selected from the cDNA library by using a 20-base deoxynucleotide probe synthesized from the published cDNA sequence (8) . The probe was treated with kinase, and the recombinant clone was selected (27) .
Gel Electrophoresis, Blotting, and Hybridization of RNA. Poly(A)+ RNA (1-2 ,ug) or total RNA (40 ,ug) samples were subjected to electrophoresis in formaldehyde/agarose gels containing borate buffer, transferred to either nitrocellulose (26) or GeneScreen (New England Nuclear), hybridized with nick-translated recombinant plasmid DNA, washed, and autoradiographed (27) . Labeled nuclear RNA was hybridized to excess plasmid DNA bound in "dots" to nitrocellulose as described (28, 29) . Between 5 x 106 and 20 x 106 cpm in 2 ml was hybridized with filters containing 6-12 dots. After being washed and treated with ribonuclease, the filters were autoradiographed (26) .
RESULTS
Poly(A)-containing RNA was prepared from human fibroblasts that had been treated with IFN-P for 5 hr. Doublestranded cDNA was made and inserted into the Pst I site of G-tailed pBR322. Colonies from this cDNA library were plated on duplicate filters, and colony hybridization was carried out with single-stranded [32P]cDNA made from poly(A)+ RNA of both IFN-p-treated and untreated cells. Colonies that hybridized only or more strongly with the probe from IFN-treated cells were selected. After a second screening, several plasmids were isolated, nick-translated, and hybridized to RNA blots containing equal concentrations of poly(A)+ RNA from either normal fibroblasts or fibroblasts treated with various concentrations of IFN-P for 5 hr. One plasmid, pIFN-IND-1 (plasmid IFN-induced-1), hybridized to a mRNA of 2.9 kb that is present only in IFN-treated cells (Fig. 1). [On high resolution gels, this large band is split into two, and mRNA selected by this clone translates into two proteins of about 42 and 58 kDa (unpublished observations).] The pIFN-IND-2 clone was originally identified by using a synthetic oligonucleotide probe prepared from the published cDNA sequence of the 56-kDa protein (8) . The mRNA that hybridizes to pIFN-IND-2 is 1.8-1.9 kb and is also present only in cells that have been exposed to IFN (Fig. 1) (26, 29) . Therefore, nuclei were isolated from human fibroblasts and HeLa cells after IFN-P treatment, and nascent labeled nuclear RNA was prepared and hybridized to DNA bound to nitrocellulose filters (Fig. 3) . The treated cells compared to the nuclei of untreated cells. The signal in untreated cells was not above the background of RNA bound to pBR322 DNA (Fig. 3) , and the signal from induced cells was at least 50-fold higher. The transcription rates were not changed for arginine tRNA, actin, /3-tubulin, and a number of other genes whose mRNA concentrations did not change after IFN-p8 treatment. By autoradiographic analysis, the transcription rate of RNA complementary to pIFN-IND-2 appeared to be somewhat greater than that to pIFN-IND-1. However, the insert size of the cDNA for pIFN-IND-2 is about 610 base pairs compared to about 200 base pairs for pIFN-IND-1. Thus, the two genes are induced to a similar degree by IFN-P3 treatment. HeLa cells also increased transcription of both genes when treated with IFN-,l. In the transcriptional analysis of HeLa cells shown in Fig.  3 , the pIFN-IND-2 cDNA hybridized considerably more RNA, but transcription of both genes was induced. Also in HeLa cell nuclei, synthesis of RNA complementary to /3 tubulin and several other genes was unchanged by IFN treatment.
A low dose of a-amanitin (0.5-5 Ag/ml) selectively inhibits the activity of RNA polymerase 11 (30) . The IFN-induced transcription of RNA to pIF-IND-1 and pIF-IND-2 were completely abolished, while the transcription of arginine tRNA (a polymerase III product) was unaffected (Fig. 3 Bottom Left). Thus, the transcription of the IFN-induced genes occurs by RNA polymerase II. present at <1/10th of their peak concentrations, indicating that synthesis ceased and turnover reduced the mRNA concentration by at least a factor of 10 between 6 and 24 hr. These results suggest that the mRNAs complementary to pIFN-IND-1 and -2 have half-lives considerably less than 8-10 hr and perhaps as short as 2-4 hr.
Both IFN type I (IFN-a and -,f) and type II (IFN-y) stimulate the antiviral state in human fibroblasts, and both types of IFN induce some common and some unique polypeptides in these cells (2, 3, 6 (2, 3, 6 ). An earlier report (8) (10) . Also Ca2+ may be involved in the ability of EGF and TRH to stimulate prolactin mRNA synthesis (12) . We tested whether these second messengers could stimulate the transcription of pIFN-IND-1 or pIFN-IND-2. Transcriptional assays were performed after treating cells with IFN-,3, with 8-bromo-cAMP, or with the calcium ionophore A23187, which increases free intracellular Ca2+ (31) . There was no increase in transcription of either IFN-responsive gene when cells were treated with 8-bromo-cAMP or with the calcium ionophore in contrast to IFN-f3 treatment (Fig. 5) is maximal by 30-60 min for both genes. Thus, within a remarkably short time, a polypeptide hormone can bind a specific cell-surface receptor and, through an undefined intracellular pathway, regulate the transcription of specific genes. The fact that neither of the IFN-p8-induced mRNAs is induced by IFN-y accords with published conclusions that type I and type II IFNs induce the antiviral state by interacting with different cell-surface receptors (17) and demonstrates the specificity of the transcriptional response reported here.
At present the nature of the intracellular events responsible for the transcriptional increase is unknown. Unlike the steroid hormones that induce the transcription of specific genes by diffusing across the plasma membrane and binding to specific intracellular receptors, polypeptides, such as the IFNs, may exert their effects without entering the cells. However, as discussed, the intracellular effect of IFN is probably not mediated by cyclic AMP or Ca2+ influx.
A number of other possible mechanisms may be postulated by which IFN-,B stimulates transcription of specific genes. It is known that most polypeptide hormone-receptor complexes are transported into the cell by receptor-mediated endocytosis (32) . In human fibroblasts, IFN-a and -y are known to be internalized and degraded in lysosomes (33, 34) . Previous studies suggest that the IFN-induced development of the antiviral state does not require that the polypeptide be internalized (18) . However, it is possible that the internalized IFN itself, the IFN receptor, or a degradation product of either could be the transcriptional activating factor. Another possible mechanism of transcriptional stimulation is intracellular protein phosphorylation stimulated by a ligandreceptor interaction at the cell surface (35, 36) . In most cases the function of hormonally stimulated phosphorylated proteins is unclear. Murdoch et al. (39) recently have suggested that the phosphorylation of a specific nuclear protein is correlated with the induction of prolactin gene expression. Although TRH-induction of prolactin transcription appears to be cyclic AMP-mediated, there are many hormones that do not act via cyclic AMP, which can stimulate the phosphorylation of intracellular proteins (36) . It would be worthwhile, therefore, to examine changes in the phosphorylated nuclear proteins of IFN-treated cells. Finally, it is becoming apparent that hormone-cell-surface receptor interactions can trigger the phosphorylation of tyrosine residues on the hormone receptor itself (37, 38) . This phosphorylation may be the initial signal for the action of such hormones as insulin or EGF. The first goal of these studies has been accomplished with the characterization of two genes whose transcription is rapidly induced by IFN-P3. It is now possible to begin to dissect the mechanism of transcriptional activation initiated by a hormone binding to a plasma membrane receptor.
While preparing our manuscript, we learned from R. L. Friedman, S. P. Manly, and G. R. Stark (personal communication) that they have selected human cDNAs complementary to seven mRNAs induced by IFN in neuroblastoma cells. At least one of these mRNA sequences is increased at the transcriptional level.
